Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
70% of people experience imposter syndrome. 93% get interview anxiety. New research shows the most qualified candidates often perform worst — here's why.
-
Washington, D.C., March 27, 2026 (GLOBE NEWSWIRE) -- Jim Rickards, the economist and former CIA advisor who famously predicted both the 2008 financial crisis and the COVID market crash, has just...
-
Solv Names Insitutional FROST Multi-Sig Partners, Raising the Bar for Decentralized Bitcoin Asset Governance
-
Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Herpafend ingredient safety, drug interactions, and supplement claim context addressed for HSV wellness consumers considering purchase in 2026
-
NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute a reverse share split for the GraniteShares 2x Long MARA Daily ETF, GraniteShares 2x Long MSTR Daily ETF, and...
-
GREAT NECK, N.Y., March 27, 2026 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that net income for the year ended December 31, 2025 was...
-
Toronto, ON, March 27, 2026 (GLOBE NEWSWIRE) -- Introduction – What Is Rastuxor? Rastuxor is presented as a modern digital trading platform engineered to deliver structured market access through a...
-
Miami, Florida, March 27, 2026 (GLOBE NEWSWIRE) -- The Arm Confidence Problem That Nobody Talks About There is a conversation happening in dressing rooms, group chats, and doctors' offices...
-
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...